Mark Saunders, MD, PhD, on Colorectal Cancer: Results From the SCOT Trial

2018 Gastrointestinal Cancers Symposium
Tweet this page

Mark Saunders, MD, PhD, of Christie Hospital, discusses study findings on tumor sidedness and the influence of chemotherapy duration on disease-free survival (Abstract 558).

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.